Lymphocyte Perturbations in Malawian Children with Severe and Uncomplicated Malaria

Clinical and Vaccine Immunology

Volumn 23, Issue 2, 2016, Pages 95-103

  Mandala, Wilson L ^a,b   Msefula, Chisomo L ^a   Gondwe, Esther N ^a,b   Gilchrist, James J ^c,d   Graham, Stephen M ^a,b,e   Pensulo, Paul ^a   Mwimaniwa, Grace ^a   Banda, Meraby ^a   Taylor, Terrie E ^f,g   Molyneux, Elizabeth E ^a   Drayson, Mark T ^h   Ward, Steven A ^b   Molyneux, Malcolm E ^a,b,f   MacLennan, Calman A ^a,h,i,j  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f Blantyre Malaria Project   (Malawi)

^g MICHIGAN STATE UNIVERSITY   (United States)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; CHILD; COMPLICATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALAWI; MALE; MORTALITY; PARASITOLOGY; PRESCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION;

ANEMIA; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INFANT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; MALARIA, CEREBRAL; MALARIA, FALCIPARUM; MALAWI; MALE; T-LYMPHOCYTE SUBSETS;

EID: 84958644125     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00564-15     Document Type: Article

References (31)

1. World Health Organization. 2011. Global Malaria Programme, World Health Organization world malaria report 2011. World Health Organization, Geneva, Switzerland. http://www.who.int/malaria/world-malaria -report-2011/en/. Accessed 29 September 2014.
2. RTS, S Clinical Trials Partnership. 2015. Efficacy and safety of RTS, S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: Final results of a phase 3, individually randomised, controlled trial. Lancet 386:31-45. http://dx.doi.org/10.1016/S0140-6736(15)60721-8.
3. Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, Duffy PE. 2008. Malaria: Progress, perils, and prospects for eradication. J Clin Invest 118:1266-1276. http://dx.doi.org/10.1172/JCI33996.
4. Engwerda CR, Good MF. 2005. Interactions between malaria parasites and the host immune system. Curr Opin Immunol 17:381-387. http://dx.doi.org/10.1016/j.coi.2005.05.010.
5. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, Davis RW, Fraser CM, Barrell B. 2002. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 419:498-511. http://dx.doi.org/10.1038/nature01097.
6. Winzeler EA. 2008. Malaria research in the post-genomic era. Nature 455:751-756. http://dx.doi.org/10.1038/nature07361.
7. Langhorne J, Ndungu FM, Sponaas AM, Marsh K. 2008. Immunity to malaria: More questions than answers. Nat Immunol 9:725-732. http://dx.doi.org/10.1038/ni.f.205.
8. Bull PC, Lowe BS, Kortok M, Molyneux CS, Newbold CI, Marsh K. 1998. Parasite antigens on the infected red cell surface are targets for naturally acquired immunity to malaria. Nat Med 4:358-360. http://dx.doi.org/10.1038/nm0398-358.
9. Riley EM. 1999. Is T-cell priming required for initiation of pathology in malaria infections? Immunol Today 20:228-233. http://dx.doi.org/10.1016/S0167-5699(99)01456-5.
10. Schofield L, Grau GE. 2005. Immunological processes in malaria pathogenesis. Nat Rev Immunol 5:722-735. http://dx.doi.org/10.1038/nri1686.
11. Chougnet C, Tallet S, Ringwald P, Deloron P. 1992. Kinetics of lymphocyte subsets from peripheral blood during a Plasmodium falciparum malaria attack. Clin Exp Immunol 90:405-408.
12. Worku S, Bjorkman A, Troye-Blomberg M, Jemaneh L, Farnert A, Christensson B. 1997. Lymphocyte activation and subset redistribution in the peripheral blood in acute malaria illness: Distinct gammadelta - T cell patterns in Plasmodium falciparum and P. vivax infections. Clin Exp Immunol 108:34-41. http://dx.doi.org/10.1046/j.1365-2249.1997.d01-981.x.
13. Hviid L, Kurtzhals JA, Goka BQ, Oliver-Commey JO, Nkrumah FK, Theander TG. 1997. Rapid reemergence of T cells into peripheral circulation following treatment of severe and uncomplicated Plasmodium falciparum malaria. Infect Immun 65:4090-4093.
14. Kassa D, Petros B, Mesele T, Hailu E, Wolday D. 2006. Characterization of peripheral blood lymphocyte subsets in patients with acute Plasmodium falciparum and P. vivax malaria infections at Wonji Sugar Estate, Ethiopia. Clin Vaccine Immunol 13:376-379. http://dx.doi.org/10.1128/CVI.13.3 .376-379.2006.
15. Korir JC, Magambo JK, Mwatha JK, Waitumbi JN. 2012. B-cell activity in children with malaria. Malar J 11:66. http://dx.doi.org/10.1186/1475-2875-11-66.
16. Gupta S, Hill AV, Kwiatkowski D, Greenwood AM, Greenwood BM, Day KP. 1994. Parasite virulence and disease patterns in Plasmodium falciparum malaria. Proc Natl Acad Sci U S A 91:3715-3719. http://dx.doi.org/10.1073/pnas.91.9.3715.
17. Mandala WL, MacLennan JM, Gondwe EN, Ward SA, Molyneux ME, MacLennan CA. 2010. Lymphocyte subsets in healthy Malawians: Implications for immunologic assessment of HIV infection in Africa. J Allergy Clin Immunol 125:203-208. http://dx.doi.org/10.1016/j.jaci.2009.10.010.
18. Jones DS, Abrams E, Ou CY, Nesheim S, Connor E, Davenny K, Thomas P, Sawyer M, Krasinski K, Bamji M. 1993. Lack of detectable human immunodeficiency virus infection in antibody-negative children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 12:222-227. http://dx.doi.org/10.1097/00006454-199303000-00010.
19. Wyler DJ. 1976. Peripheral lymphocyte subpopulations in human falciparum malaria. Clin Exp Immunol 23:471-476.
20. Greenwood BM, Oduloju AJ, Stratton D. 1977. Lymphocyte changes in acute malaria. Trans R Soc Trop Med Hyg 71:408-410. http://dx.doi.org/10.1016/0035-9203(77)90039-6.
21. Maina RN, Walsh D, Gaddy C, Hongo G, Waitumbi J, Otieno L, Jones D, Ogutu BR. 2010. Impact of Plasmodium falciparum infection on haematological parameters in children living in Western Kenya. Malar J 9(Suppl 3):S4. http://dx.doi.org/10.1186/1475-2875-9-S3-S4.
22. Olliaro P, Djimde A, Dorsey G, Karema C, Mårtensson A, Ndiaye JL, Sirima SB, Vaillant M, Zwang J. 2011. Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. Am J Trop Med Hyg 85:619-625. http://dx.doi.org/10.4269/ajtmh .2011.11-0154.
23. Hviid L, Kemp K. 2000. What is the cause of lymphopenia in malaria? Infect Immun 68:6087-6089. http://dx.doi.org/10.1128/IAI.68.10.6087-6089.2000.
24. Kern P, Dietrich M, Hemmer C, Wellinghausen N. 2000. Increased levels of soluble Fas ligand in serum in Plasmodium falciparum malaria. Infect Immun 68:3061-3063. http://dx.doi.org/10.1128/IAI.68.5.3061-3063.2000.
25. Matsumoto J, Kawai S, Terao K, Kirinoki M, Yasutomi Y, Aikawa M, Matsuda H. 2000. Malaria infection induces rapid elevation of the soluble Fas ligand level in serum and subsequent T lymphocytopenia: Possible factors responsible for the differences in susceptibility of two species of Macaca monkeys to Plasmodium coatneyi infection. Infect Immun 68: 1183-1188. http://dx.doi.org/10.1128/IAI.68.3.1183-1188.2000.
26. Zijenah LS, Katzenstein DA, Nathoo KJ, Rusakaniko S, Tobaiwa O, Gwanzura C, Bikoue A, Nhembe M, Matibe P, Janossy G. 2005. T lymphocytes among HIV-infected and-uninfected infants: CD4/CD8 RaTiO As a pOtEnTiAl tOoL In dIaGnOsIs oF InFeCtIoN In infants under the age of 2 years. J Transl Med 3:6. http://dx.doi.org/10.1186/1479-5876-3-6.
27. D'Ombrain MC, Hansen DS, Simpson KM, Schofield L. 2007. Gammadelta-T cells expressing NK receptors predominate over NK cells and conventional T cells in the innate IFN-gamma response to Plasmodium falciparum malaria. Eur J Immunol 37:1864-1873. http://dx.doi.org/10.1002/eji.200636889.
28. Horowitz A, Newman KC, Evans JH, Korbel DS, Davis DM, Riley EM. 2010. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J Immunol 184:6043-6052. http://dx.doi.org/10.4049/jimmunol.1000106.
29. Stanisic DI, Cutts J, Eriksson E, Fowkes FJI, Rosanas-Urgell A, Siba P, Laman M, Davis TME, Manning L, Mueller I, Schofield L. 2014. -T cells and CD14- monocytes are predominant cellular sources of cytokines and chemokines associated with severe malaria. J Infect Dis 210:295-305. http://dx.doi.org/10.1093/infdis/jiu083.
30. Shiow LR, Rosen DB, Brdickova N, Xu Y, An J, Lanier LL, Cyster JG, Matloubian M. 2006. CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs. Nature 440: 540-544. http://dx.doi.org/10.1038/nature04606.
31. Van Hensbroek MB, Palmer A, Onyiorah E, Schneider G, Jaffar S, Dolan G, Memming H, Frenkel J, Enwere G, Bennett S, Kwiatkowski D, Greenwood B. 1996. The effect of a monoclonal antibody to tumor necrosis factor on survival from childhood cerebral malaria. J Infect Dis 174:1091-1097. http://dx.doi.org/10.1093/infdis/174.5.1091.